Article
Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC.
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) - 1 Dec 2023
Cheng Yuan, Wang Huan, Yuan Wendi, Wang Haotian, Zhu Yuheng, Chen Huanhuan, Jiang Wenyan
Abstract excerpt
PURPOSE: To develop radiomics models of primary tumour and spinal metastases to predict epidermal growth factor receptor (EGFR) mutations and therapeutic response to EGFR-tyrosine kinase inhibitor (TKI) in patients with metastatic non-small-cell lung cancer (NSCLC). METHODS: We enrolled 203 patients with spinal metastases between December 2017 and September 2021, classified as patients with the EGFR mutation or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
